About one in seven Medicare beneficiaries is diagnosed with heart failure (HF) with two-thirds of them presenting five or more comorbidities. Part D spending by HF patients is higher than for other patients due to their condition and related comorbidities. They are more likely to reach the coverage gap and catastrophic spending zones than the average Part D beneficiary. This paper examines the Part D spending of Medicare patients with HF.
This article was commissioned by Novartis Pharmaceuticals Corporation.